http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Adherence to a risk-adapted screening strategy for prostate cancer - first results of the PROBASE trial
Krilaviciute, A. (First author)DKFZ* ; Albers, P. (First author)DKFZ* ; Lakes, J. ; Radtke, J. P. ; Herkommer, K. ; Gschwend, J. ; Peters, I. ; Kuczyk, M. ; Koerber, S. A. ; Debus, J. ; Kristiansen, G. ; Schimmöller, L. ; Antoch, G. ; Makowski, M. ; Wacker, F. ; Schlemmer, H.DKFZ* ; Benner, A.DKFZ* ; Giesel, F. ; Siener, R. ; Arsov, C. ; Hadaschik, B. ; Becker, N. (Last author)DKFZ* ; Kaaks, R. (Last author)DKFZ*
2023
Wiley-Liss
Bognor Regis
This record in other databases:

Please use a persistent id in citations: doi:10.1002/ijc.34295
Note: #EA:C130#LA:C130#LA:C020# / 2023 Mar 1;152(5):854-864
Contributing Institute(s):
- Personalisierte Früherkennung des Prostatakarzinoms (C130)
- E010 Radiologie (E010)
- C060 Biostatistik (C060)
Research Program(s):
- 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)
Appears in the scientific report
2022
Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz

; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection